Constellation Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference
13 Juin 2019 - 8:57PM
Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a
clinical-stage biopharmaceutical company using its expertise in
epigenetics to discover and develop novel therapeutics, today
announced that Jigar Raythatha, CEO, will present at the BMO
Prescriptions for Success Healthcare Conference in New York at 3:20
PM EDT on June 25. A live audio webcast of the presentation and an
archive for replay will be available on the Investor Relations
section of Constellation’s website at
http://ir.constellationpharma.com/events-and-presentations/events.
The audio webcast replay will be available for 180 days following
the live presentation.
About Constellation
Pharmaceuticals
Constellation Pharmaceuticals is a
clinical-stage biopharmaceutical company developing novel
therapeutics that selectively modulate gene expression to address
serious unmet medical needs in patients with cancer. The Company
has a deep understanding of how epigenetic and chromatin
modifications in cancer cells and in the tumor and immune
microenvironment play a fundamental role in driving disease
progression and drug resistance. Constellation is driving
development of the EZH2 inhibitors CPI-1205 and CPI-0209 for the
treatment of metastatic castration-resistant prostate cancer and
other cancers as well as the BET inhibitor CPI-0610 for the
treatment of myelofibrosis. The Company is also applying its broad
research and development capabilities to explore other novel
targets that directly and indirectly impact gene expression to fuel
a sustainable pipeline of innovative small-molecule product
candidates.
Contact Ronald Aldridge
Investor RelationsConstellation Pharmaceuticals+1
617-714-0539ron.aldridge@constellationpharma.com
Lauren ArnoldMedia RelationsMacDougall
Biomedical Communications+1 781-235-3060larnold@macbiocom.com
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Constellation Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur